Form 4: Quest Diagnostics EVP Catherine T. Doherty Reports Sale of Common Stock
SEC Form 4 Filing
Catherine T. Doherty, EVP of Regional Businesses at Quest Diagnostics, reported the sale of 5,370 shares of common stock on March 5, 2025, at a price of $174.13 per share.
Summary
- Catherine T. Doherty, an Executive Vice President at Quest Diagnostics, filed a Form 4 indicating changes in beneficial ownership of the company's stock.
- On March 5, 2025, Ms. Doherty sold 5,370 shares of Quest Diagnostics common stock at a price of $174.13 per share.
- Following the transaction, Ms. Doherty directly owns 68,068 shares of common stock.
- She also indirectly owns 4,427 shares through the company's 401(k) and Supplemental Deferred Compensation Plan.
- The sale was executed under a pre-arranged Rule 10b5-1 sales plan.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was pre-planned under a 10b5-1 plan and doesn't necessarily reflect a change in the executive's outlook on the company.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the buying and selling activities of company executives and directors. This allows investors to gain insights into management's perspective on the company's stock and future prospects.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of the stock sale transaction. |
| 03/07/2025 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.